L'intérêt à découvert pour Bukit Jalil Global Acquisition 1 Ltd. - Rights donne aux investisseurs une idée du degré auquel les investisseurs parient sur la baisse de l'action de Bukit Jalil Global Acquisition 1 Ltd. - Rights. Les données sur l'intérêt à découvert sont mises à jour toutes les deux semaines.

Bukit Jalil Global Acquisition 1 Ltd. - Rights (NASDAQ:BUJAR) Stock, Rapport sur les intérêts à découvert

Bukit Jalil Global Acquisition 1 Ltd. - Rights

Armada Hoffler Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHH#NYSE">AHH</a>) affirms FY2025 FFO guidance from $1.00-$1.10 to $1.00-$1.10 vs $1.06 analyst estimate..

News

Guidance

Armada Hoffler Properties Affirms FY2025 FFO Guidance of $1.00-$1.10 vs $1.06 Est

Based on our first quarter 2025 results and our outlook for the remainder of the year, we are reaffirming 2025 full year guidance for all financial measures.
<ul>
<li>Total Revenue of $925 million to $935 million</li>
<li>Adjusted EBITDA of $410 million to $420 million</li>
<li>Adjusted EPS of $1.30 to $1.35</li>
<li>Free Cash Flow of $175 million to $185 million</li>
</ul>

VRRM

Verra Mobility Affirms FY2025 Adj EPS Guidance of $1.30-$1.35 vs $1.32 Est; Affirms FY2025 Sales Guidance of $925.00M-$935.00M vs $931.57M Est

ON24 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) Q2 expected to be below $0.02 vs $0.01 Est. sees Q2 sales of $33.800 million-$34.400 million vs $35.17 million analyst estimate.

ONTF

ON24 Q2  expected to be below $0.02 vs $0.01 Est; Sees Q2 Sales $33.800M-$34.400M vs $35.17M Est

WIIM

AXON

Axon Enterprise shares are trading higher after the company reported better-than-expected Q1 financial results and raised FY25 sales guidance.

Silvaco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVCO#NASDAQ">SVCO</a>) is looking for Q2 Adj EPS of $(0.10)-$(0.03) vs $0.04 analyst estimate. sees sales of $12.000 million-$16.000 million vs $17.20 million analyst estimate.

SVCO

Silvaco Group Sees Q2 Adj EPS $(0.10)-$(0.03) vs $0.04 Est; Sees Sales $12.000M-$16.000M vs $17.20M Est

Armada Hoffler Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AHH#NYSE">AHH</a>) reported quarterly earnings of $0.25 per share which missed the analyst consensus estimate of $0.26 by 3.85 percent. This is a 24.24 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $63.80 million which beat the analyst consensus estimate of $63.18 million by 0.98 percent. This is a 3.10 percent increase over sales of $61.88 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

Armada Hoffler Properties Q1 FFO $0.25 Misses $0.26 Estimate, Sales $63.80M Beat $63.18M Estimate

ON24 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) affirms FY2025 Adj EPS guidance from $0.02-$0.05 to $0.02-$0.05 vs $0.03 analyst estimate. Lowers FY2025 sales outlook from $138.60 million-$141.60 million to $133.70 million-$136.70 million vs $139.82 million estimate.

ON24 Affirms FY2025 Adj EPS Guidance of $0.02-$0.05 vs $0.03 Est; Lowers FY2025 Sales Guidance from $138.60M-$141.60M to $133.70M-$136.70M vs $139.82M Est

Crane NXT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CXT#NYSE">CXT</a>) affirms FY2025 Adj EPS guidance from $4.00-$4.30 to $4.00-$4.30 vs $4.13 analyst estimate..

Crane NXT Affirms FY2025 Adj EPS Guidance of $4.00-$4.30 vs $4.13 Est; Sales Growth Of 6% To 8%

Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) reported quarterly earnings of $1.07 per share which beat the analyst consensus estimate of $(0.06) by 1883.33 percent. This is a 354.76 percent increase over losses of $(0.42) per share from the same period last year. The company reported quarterly sales of $349.40 million which beat the analyst consensus estimate of $322.66 million by 8.29 percent. This is a 37.07 percent increase over sales of $254.90 million the same period last year.

ROOT

Root Q1 GAAP EPS $1.07, Sales $349.40M Beat $322.66M Estimate

IONQ

IonQ Q1 EPS $(0.14) Beats $(0.23) Estimate, Sales $7.57M Beat $7.51M Estimate

Verra Mobility (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRRM#NASDAQ">VRRM</a>) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.29 by 3.45 percent. This is a 11.11 percent increase over earnings of $0.27 per share from the same period last year. The company reported quarterly sales of $223.25 million which beat the analyst consensus estimate of $216.95 million by 2.90 percent. This is a 6.45 percent increase over sales of $209.73 million the same period last year.

Verra Mobility Q1 Adj. EPS $0.30 Beats $0.29 Estimate, Sales $223.25M Beat $216.95M Estimate

RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) affirms FY2025 sales outlook from $160.00 million-$175.00 million to $160.00 million-$175.00 million vs $170.30 million estimate.

RXST

RxSight Affirms FY2025 Sales Guidance of $160.00M-$175.00M vs $170.30M Est

Lesaka Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSAK#NASDAQ">LSAK</a>) expect revenue between ZAR 11.4 billion and ZAR 12.2 billion.

LSAK

Lesaka Technologies expect revenue between ZAR 11.4 billion and ZAR 12.2 billion for FY 2026

Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) sees Q2 sales of $89.000 million-$91.000 million vs $92.73 million analyst estimate.

INGN

Inogen Sees Q2 Sales $89.000M-$91.000M vs $92.73M Est

<a href="https://www.politico.com/news/2025/05/07/trump-sweeping-medicare-drug-price-plan-00334167" title="https://www.politico.com/news/2025/05/07/trump-sweeping-medicare-drug-price-plan-00334167">https://www.politico.com/news/2025/05/07/trump-sweeping-medicare-drug-price-plan-00334167</a>

Macro Economic Events

Econ #s

Economics

"Trump To Pitch Sweeping Medicare Drug Price Plan"- Politico

ON24 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONTF#NYSE">ONTF</a>) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.03) by 66.67 percent. This is a 150 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $34.73 million which beat the analyst consensus estimate of $34.23 million by 1.48 percent. This is a 7.94 percent decrease over sales of $37.73 million the same period last year.

ON24 Q1 Adj. EPS $(0.01) Beats $(0.03) Estimate, Sales $34.73M Beat $34.23M Estimate

FTNT

Fortinet shares are trading lower. The company reported Q1 financial results.

NOTV

Inotiv Q2 Sales $124.30M Beat $123.96M Estimate

RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.22) by 86.36 percent. This is a 75 percent increase over losses of $(0.12) per share from the same period last year. The company reported quarterly sales of $37.90 million which missed the analyst consensus estimate of $38.12 million by 0.58 percent. This is a 28.41 percent increase over sales of $29.51 million the same period last year.

RxSight Q1 Adj. EPS $(0.03) Beats $(0.22) Estimate, Sales $37.90M Miss $38.12M Estimate

Inogen (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INGN#NASDAQ">INGN</a>) affirms FY2025 sales outlook from $352.00 million-$355.00 million to $352.00 million-$355.00 million vs $352.81 million estimate.

Comments

Bukit Jalil Global Acquisition 1 Ltd. - Rights

Intérêt court

Bukit Jalil Global Acquisition 1 Ltd. - Rights (NASDAQ:BUJAR) Stock, Rapport sur les intérêts à découvert

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL